Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Aradhana Kari
Regulatory Coordinator II
Cancer Center Division
Overview
Research
More
Collaboration
(8)
Setsuko Chambers
Mutual work: 4 Grants﹒6 Proposals
Collaboration Details
Janiel Cragun
Mutual work: 6 Proposals﹒4 Grants
Collaboration Details
Brianna Denton
Mutual work: 1 Supervisor
Collaboration Details
Mitzi Miranda
Mutual work: 4 Grants﹒6 Proposals
Collaboration Details
Carolyn Lane
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Page 1 of 2
Previous page
Next page
Grants
(4)
A Phase 3 Study of Relacorilant in Combination with Nab-Paclitaxel versus Nab-Paclitaxel Monotherapy in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tu
Active
·
2023
·
$0 / $560.9K
·
External
ovarian cancer,
combination therapy,
platinum-resistant,
peritoneal cancer,
fallopian-tube cancer
A Randomized Phase 3 Study Assessing the Efficacy and Safety of Olvi-Vec followed by Platinum-doublet Chemotherapy and Bevacizumab Compared with Platinum-doublet Chemotherapy and Bevacizumab in Women
Active
·
2023
·
$0 / $270.2K
·
External
clinical trials,
cancer treatment,
immunotherapy,
chemotherapy,
women's health
A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study of Upifitamab Rilsodotin (XMT-1536) as Post-Platnum Maintenance Therapy for Participants with Recurrent, Platinum-Sensitive
2023
·
$0 / $217.6K
·
External
cancer therapy,
clinical trial,
pharmacology,
immunotherapy,
drug development
A Phase 1/2 Dose Escalation and Dose Expansion Study of ZNc3 in Combination with Niraparib in Subjects with Platinum Resistant Ovarian Cancer
2023
·
$0 / $18.4K
·
External
ovarian cancer,
drug combination,
dose escalation,
clinical trial,
platinum-resistant
